ATE42750T1 - Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents
Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.Info
- Publication number
- ATE42750T1 ATE42750T1 AT85402528T AT85402528T ATE42750T1 AT E42750 T1 ATE42750 T1 AT E42750T1 AT 85402528 T AT85402528 T AT 85402528T AT 85402528 T AT85402528 T AT 85402528T AT E42750 T1 ATE42750 T1 AT E42750T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- tetrapeptides
- gastric
- elimination
- tri
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8419545A FR2575164B1 (fr) | 1984-12-20 | 1984-12-20 | Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant |
EP85402528A EP0187095B1 (de) | 1984-12-20 | 1985-12-18 | Ester von Tri- und Tetrapeptiden, Hemmungsstoff gastrischer Ausscheidung, Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE42750T1 true ATE42750T1 (de) | 1989-05-15 |
Family
ID=9310829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85402528T ATE42750T1 (de) | 1984-12-20 | 1985-12-18 | Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4687759A (de) |
EP (1) | EP0187095B1 (de) |
JP (1) | JPS61197595A (de) |
AT (1) | ATE42750T1 (de) |
CA (1) | CA1275550C (de) |
DE (1) | DE3569930D1 (de) |
FR (1) | FR2575164B1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE114160T1 (de) * | 1989-01-24 | 1994-12-15 | Aphton Corp | Immunogenische zusammensetzungen gegen gastrin- peptide. |
US6861510B1 (en) | 1989-01-24 | 2005-03-01 | Aphton Corporation | Immunogenic compositions against gastrin peptides |
US5023077A (en) * | 1989-01-24 | 1991-06-11 | Aphton Corporation | Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease |
US20030068326A1 (en) * | 1998-05-15 | 2003-04-10 | Aphton Corporation | Method for the treatment of gastroesophageal reflux disease |
AU4080399A (en) * | 1998-05-15 | 1999-12-06 | Aphton Corporation | Prevention and treatment of hypergastrinemia |
US20030091574A1 (en) * | 2001-03-23 | 2003-05-15 | Gevas Philip C. | Combination treatment of pancreatic cancer |
US20090191232A1 (en) * | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
AU2002326356A1 (en) * | 2001-07-09 | 2003-01-29 | Aphton Corporation | Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
US6810583B2 (en) * | 2001-08-07 | 2004-11-02 | International Business Machines Corporation | Coupling of conductive vias to complex power-signal substructures |
EP1608984A2 (de) * | 2003-03-28 | 2005-12-28 | Aphton Corporation | Gastrin hormon immunoassays |
EP1730193A2 (de) * | 2004-03-29 | 2006-12-13 | Receptor Biologix, Inc. | Monoklonale antikörper gegen gastrinhormon |
ES2400058T3 (es) * | 2004-09-22 | 2013-04-05 | Cancer Advances, Inc. | Anticuerpos monoclonales para progastrina |
EP3624841A4 (de) | 2017-06-15 | 2021-01-27 | Cancer Advances, Inc., | Zusammensetzungen und verfahren zur induzierung humoraler und zellulärer immunitäten gegen tumore und krebs |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1042487A (en) * | 1964-06-25 | 1966-09-14 | Ici Ltd | Polypeptide derivatives |
US3875137A (en) * | 1973-04-20 | 1975-04-01 | Searle & Co | N-Substituted aspactyl peptide amids |
US4012367A (en) * | 1976-02-05 | 1977-03-15 | G. D. Searle & Co. | Anti-ulcer polypeptides containing L-aspartic acid and intermediates thereto |
HU175152B (hu) * | 1976-12-30 | 1980-05-28 | Richter Gedeon Vegyeszet | Sposob poluchenija peptidov s gastrin-aktivnost'ju, soderzhahhikh amino-oksi-kisloty |
FR2537971A1 (fr) * | 1982-12-16 | 1984-06-22 | Commissariat Energie Atomique | Nouveaux derives peptidiques, leur procede de fabrication et leur utilisation pharmaceutique |
-
1984
- 1984-12-20 FR FR8419545A patent/FR2575164B1/fr not_active Expired
-
1985
- 1985-12-16 CA CA000497718A patent/CA1275550C/en not_active Expired - Fee Related
- 1985-12-16 US US06/808,959 patent/US4687759A/en not_active Expired - Fee Related
- 1985-12-18 DE DE8585402528T patent/DE3569930D1/de not_active Expired
- 1985-12-18 EP EP85402528A patent/EP0187095B1/de not_active Expired
- 1985-12-18 AT AT85402528T patent/ATE42750T1/de not_active IP Right Cessation
- 1985-12-20 JP JP60287593A patent/JPS61197595A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2575164A1 (fr) | 1986-06-27 |
EP0187095A1 (de) | 1986-07-09 |
US4687759A (en) | 1987-08-18 |
JPS61197595A (ja) | 1986-09-01 |
FR2575164B1 (fr) | 1987-03-20 |
CA1275550C (en) | 1990-10-23 |
EP0187095B1 (de) | 1989-05-03 |
DE3569930D1 (en) | 1989-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE42750T1 (de) | Ester von tri- und tetrapeptiden, hemmungsstoff gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DE3166150D1 (en) | N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation | |
DE3484691D1 (de) | Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
IL67965A0 (en) | Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt thereof,certain compounds derived from 3-hydroxybutanoic acid and their preparation | |
NZ296479A (en) | Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp) | |
DE3875538D1 (de) | Aminoluciferine, verfahren zu deren herstellung und ihre verwendung. | |
ES8406438A1 (es) | Procedimiento para preparar nuevos derivados de aminoacidos triciclicos | |
IL67552A0 (en) | Cyclic octapeptides,their preparation and pharmaceutical compositions containing them | |
ES8402559A1 (es) | Un procedimiento para preparar nuevos compuestos peptidicos. | |
ES8501364A1 (es) | Un metodo para la preparacion de nuevos polipeptidos. | |
HU896606D0 (en) | Process for the preparation of aminoacid derivatives inhibiting enzymes and pharmaceutical compositions thereof | |
ATE45165T1 (de) | Reduzierte peptide, hemmungsstoffe gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE30919T1 (de) | Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
DK137085D0 (da) | Fremgangsmaade og mellemprodukter til fremstilling af racematfattigepeptider | |
JPS6393796A (ja) | ペプチド合成の脱保護基用薬剤 | |
ATE1060T1 (de) | Dipeptide zur verwendung bei der heilung von krankheiten, einige neue stoffe aus dieser verbindungsgruppe, dipeptide enthaltende arzneimittel und deren herstellung. | |
Chassaing et al. | Transformation of methionine into S-tert-butylhomocysteine. Application to a methionine-containing peptide: Substance P | |
AU1779088A (en) | Guanidine-related compounds comprising a tetraphenylborate ion, process for obtaining these compounds and use of the compounds in peptide synthesis | |
DE3650564D1 (de) | Dipeptide-Analoge von Aspertam und Verfahren zur deren Herstellung, sowie eine neue Herstellung von Aspertam | |
DE69324019T2 (de) | Pyridinyl/quinolinyl-endgruppen enthaltende alkylamino-ethynyl-alanin-amindiol derivate zur behandlung von bluthochdruck | |
ATE3205T1 (de) | Psycho-pharmakologische peptide, verfahren zu ihrer herstellung und sie enthaltende therapeutische zusammensetzungen. | |
DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it | |
IT1270613B (it) | Lattami biciclici come intermedi per la sintesi di peptidi biologicamente attivi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |